Global Vaccine (Include COVID-19) Market Research Report 2024, Forecast to 2032
Report Overview
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global Vaccine (Include COVID-19) market size was estimated at USD 140120 million in 2023 and is projected to reach USD 194316.17 million by 2032, exhibiting a CAGR of 3.70% during the forecast period.
North America Vaccine (Include COVID-19) market size was estimated at USD 38863.85 million in 2023, at a CAGR of 3.17% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Vaccine (Include COVID-19) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine (Include COVID-19) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine (Include COVID-19) market in any manner.
Global Vaccine (Include COVID-19) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
KM Biologics
Pfizer
Merck
Sinovac
Zhejiang Pukang
Walvax Biotechnology
Bharat Biotech
Serum Institute
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
LG Life Sciences
Market Segmentation (by Type)
Inactivated Vaccine
Attenuated Vaccine
mRNA
Other
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine (Include COVID-19) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Vaccine (Include COVID-19), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The global Vaccine (Include COVID-19) market size was estimated at USD 140120 million in 2023 and is projected to reach USD 194316.17 million by 2032, exhibiting a CAGR of 3.70% during the forecast period.
North America Vaccine (Include COVID-19) market size was estimated at USD 38863.85 million in 2023, at a CAGR of 3.17% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Vaccine (Include COVID-19) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine (Include COVID-19) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine (Include COVID-19) market in any manner.
Global Vaccine (Include COVID-19) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
KM Biologics
Pfizer
Merck
Sinovac
Zhejiang Pukang
Walvax Biotechnology
Bharat Biotech
Serum Institute
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
LG Life Sciences
Market Segmentation (by Type)
Inactivated Vaccine
Attenuated Vaccine
mRNA
Other
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Vaccine (Include COVID-19) Market
- Overview of the regional outlook of the Vaccine (Include COVID-19) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine (Include COVID-19) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Vaccine (Include COVID-19), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Vaccine (Include COVID-19)
1.2 Key Market Segments
1.2.1 Vaccine (Include COVID-19) Segment by Type
1.2.2 Vaccine (Include COVID-19) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCINE (INCLUDE COVID-19) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccine (Include COVID-19) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Vaccine (Include COVID-19) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VACCINE (INCLUDE COVID-19) MARKET COMPETITIVE LANDSCAPE
3.1 Global Vaccine (Include COVID-19) Sales by Manufacturers (2019-2024)
3.2 Global Vaccine (Include COVID-19) Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaccine (Include COVID-19) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaccine (Include COVID-19) Sales Sites, Area Served, Product Type
3.6 Vaccine (Include COVID-19) Market Competitive Situation and Trends
3.6.1 Vaccine (Include COVID-19) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaccine (Include COVID-19) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VACCINE (INCLUDE COVID-19) INDUSTRY CHAIN ANALYSIS
4.1 Vaccine (Include COVID-19) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCINE (INCLUDE COVID-19) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VACCINE (INCLUDE COVID-19) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine (Include COVID-19) Sales Market Share by Type (2019-2024)
6.3 Global Vaccine (Include COVID-19) Market Size Market Share by Type (2019-2024)
6.4 Global Vaccine (Include COVID-19) Price by Type (2019-2024)
7 VACCINE (INCLUDE COVID-19) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine (Include COVID-19) Market Sales by Application (2019-2024)
7.3 Global Vaccine (Include COVID-19) Market Size (M USD) by Application (2019-2024)
7.4 Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2019-2024)
8 VACCINE (INCLUDE COVID-19) MARKET CONSUMPTION BY REGION
8.1 Global Vaccine (Include COVID-19) Sales by Region
8.1.1 Global Vaccine (Include COVID-19) Sales by Region
8.1.2 Global Vaccine (Include COVID-19) Sales Market Share by Region
8.2 North America
8.2.1 North America Vaccine (Include COVID-19) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vaccine (Include COVID-19) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vaccine (Include COVID-19) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vaccine (Include COVID-19) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vaccine (Include COVID-19) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 VACCINE (INCLUDE COVID-19) MARKET PRODUCTION BY REGION
9.1 Global Production of Vaccine (Include COVID-19) by Region (2019-2024)
9.2 Global Vaccine (Include COVID-19) Revenue Market Share by Region (2019-2024)
9.3 Global Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Vaccine (Include COVID-19) Production
9.4.1 North America Vaccine (Include COVID-19) Production Growth Rate (2019-2024)
9.4.2 North America Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Vaccine (Include COVID-19) Production
9.5.1 Europe Vaccine (Include COVID-19) Production Growth Rate (2019-2024)
9.5.2 Europe Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Vaccine (Include COVID-19) Production (2019-2024)
9.6.1 Japan Vaccine (Include COVID-19) Production Growth Rate (2019-2024)
9.6.2 Japan Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Vaccine (Include COVID-19) Production (2019-2024)
9.7.1 China Vaccine (Include COVID-19) Production Growth Rate (2019-2024)
9.7.2 China Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Vaccine (Include COVID-19) Basic Information
10.1.2 Sanofi Vaccine (Include COVID-19) Product Overview
10.1.3 Sanofi Vaccine (Include COVID-19) Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi Vaccine (Include COVID-19) SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Vaccine (Include COVID-19) Basic Information
10.2.2 CSL Vaccine (Include COVID-19) Product Overview
10.2.3 CSL Vaccine (Include COVID-19) Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL Vaccine (Include COVID-19) SWOT Analysis
10.2.6 CSL Recent Developments
10.3 GSK
10.3.1 GSK Vaccine (Include COVID-19) Basic Information
10.3.2 GSK Vaccine (Include COVID-19) Product Overview
10.3.3 GSK Vaccine (Include COVID-19) Product Market Performance
10.3.4 GSK Vaccine (Include COVID-19) SWOT Analysis
10.3.5 GSK Business Overview
10.3.6 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Vaccine (Include COVID-19) Basic Information
10.4.2 Viatris Vaccine (Include COVID-19) Product Overview
10.4.3 Viatris Vaccine (Include COVID-19) Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Vaccine (Include COVID-19) Basic Information
10.5.2 AstraZeneca Vaccine (Include COVID-19) Product Overview
10.5.3 AstraZeneca Vaccine (Include COVID-19) Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Vaccine (Include COVID-19) Basic Information
10.6.2 Hualan Bio Vaccine (Include COVID-19) Product Overview
10.6.3 Hualan Bio Vaccine (Include COVID-19) Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Vaccine (Include COVID-19) Basic Information
10.7.2 Changchun Institute of Biological Vaccine (Include COVID-19) Product Overview
10.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Product Market Performance
10.7.4 Changchun Institute of Biological Business Overview
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Vaccine (Include COVID-19) Basic Information
10.8.2 Sinovac Vaccine (Include COVID-19) Product Overview
10.8.3 Sinovac Vaccine (Include COVID-19) Product Market Performance
10.8.4 Sinovac Business Overview
10.8.5 Sinovac Recent Developments
10.9 KM Biologics
10.9.1 KM Biologics Vaccine (Include COVID-19) Basic Information
10.9.2 KM Biologics Vaccine (Include COVID-19) Product Overview
10.9.3 KM Biologics Vaccine (Include COVID-19) Product Market Performance
10.9.4 KM Biologics Business Overview
10.9.5 KM Biologics Recent Developments
10.10 Pfizer
10.10.1 Pfizer Vaccine (Include COVID-19) Basic Information
10.10.2 Pfizer Vaccine (Include COVID-19) Product Overview
10.10.3 Pfizer Vaccine (Include COVID-19) Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
10.11 Merck
10.11.1 Merck Vaccine (Include COVID-19) Basic Information
10.11.2 Merck Vaccine (Include COVID-19) Product Overview
10.11.3 Merck Vaccine (Include COVID-19) Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 Sinovac
10.12.1 Sinovac Vaccine (Include COVID-19) Basic Information
10.12.2 Sinovac Vaccine (Include COVID-19) Product Overview
10.12.3 Sinovac Vaccine (Include COVID-19) Product Market Performance
10.12.4 Sinovac Business Overview
10.12.5 Sinovac Recent Developments
10.13 Zhejiang Pukang
10.13.1 Zhejiang Pukang Vaccine (Include COVID-19) Basic Information
10.13.2 Zhejiang Pukang Vaccine (Include COVID-19) Product Overview
10.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Product Market Performance
10.13.4 Zhejiang Pukang Business Overview
10.13.5 Zhejiang Pukang Recent Developments
10.14 Walvax Biotechnology
10.14.1 Walvax Biotechnology Vaccine (Include COVID-19) Basic Information
10.14.2 Walvax Biotechnology Vaccine (Include COVID-19) Product Overview
10.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Product Market Performance
10.14.4 Walvax Biotechnology Business Overview
10.14.5 Walvax Biotechnology Recent Developments
10.15 Bharat Biotech
10.15.1 Bharat Biotech Vaccine (Include COVID-19) Basic Information
10.15.2 Bharat Biotech Vaccine (Include COVID-19) Product Overview
10.15.3 Bharat Biotech Vaccine (Include COVID-19) Product Market Performance
10.15.4 Bharat Biotech Business Overview
10.15.5 Bharat Biotech Recent Developments
10.16 Serum Institute
10.16.1 Serum Institute Vaccine (Include COVID-19) Basic Information
10.16.2 Serum Institute Vaccine (Include COVID-19) Product Overview
10.16.3 Serum Institute Vaccine (Include COVID-19) Product Market Performance
10.16.4 Serum Institute Business Overview
10.16.5 Serum Institute Recent Developments
10.17 Panacea Biotec Ltd
10.17.1 Panacea Biotec Ltd Vaccine (Include COVID-19) Basic Information
10.17.2 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Overview
10.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Market Performance
10.17.4 Panacea Biotec Ltd Business Overview
10.17.5 Panacea Biotec Ltd Recent Developments
10.18 Bio-Med
10.18.1 Bio-Med Vaccine (Include COVID-19) Basic Information
10.18.2 Bio-Med Vaccine (Include COVID-19) Product Overview
10.18.3 Bio-Med Vaccine (Include COVID-19) Product Market Performance
10.18.4 Bio-Med Business Overview
10.18.5 Bio-Med Recent Developments
10.19 Halfkin Bio-Pharmaceuticals
10.19.1 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Basic Information
10.19.2 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Overview
10.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Market Performance
10.19.4 Halfkin Bio-Pharmaceuticals Business Overview
10.19.5 Halfkin Bio-Pharmaceuticals Recent Developments
10.20 LG Life Sciences
10.20.1 LG Life Sciences Vaccine (Include COVID-19) Basic Information
10.20.2 LG Life Sciences Vaccine (Include COVID-19) Product Overview
10.20.3 LG Life Sciences Vaccine (Include COVID-19) Product Market Performance
10.20.4 LG Life Sciences Business Overview
10.20.5 LG Life Sciences Recent Developments
11 VACCINE (INCLUDE COVID-19) MARKET FORECAST BY REGION
11.1 Global Vaccine (Include COVID-19) Market Size Forecast
11.2 Global Vaccine (Include COVID-19) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaccine (Include COVID-19) Market Size Forecast by Country
11.2.3 Asia Pacific Vaccine (Include COVID-19) Market Size Forecast by Region
11.2.4 South America Vaccine (Include COVID-19) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Vaccine (Include COVID-19) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Vaccine (Include COVID-19) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Vaccine (Include COVID-19) by Type (2025-2032)
12.1.2 Global Vaccine (Include COVID-19) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Vaccine (Include COVID-19) by Type (2025-2032)
12.2 Global Vaccine (Include COVID-19) Market Forecast by Application (2025-2032)
12.2.1 Global Vaccine (Include COVID-19) Sales (K MT) Forecast by Application
12.2.2 Global Vaccine (Include COVID-19) Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Vaccine (Include COVID-19)
1.2 Key Market Segments
1.2.1 Vaccine (Include COVID-19) Segment by Type
1.2.2 Vaccine (Include COVID-19) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCINE (INCLUDE COVID-19) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccine (Include COVID-19) Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Vaccine (Include COVID-19) Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VACCINE (INCLUDE COVID-19) MARKET COMPETITIVE LANDSCAPE
3.1 Global Vaccine (Include COVID-19) Sales by Manufacturers (2019-2024)
3.2 Global Vaccine (Include COVID-19) Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaccine (Include COVID-19) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaccine (Include COVID-19) Sales Sites, Area Served, Product Type
3.6 Vaccine (Include COVID-19) Market Competitive Situation and Trends
3.6.1 Vaccine (Include COVID-19) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaccine (Include COVID-19) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VACCINE (INCLUDE COVID-19) INDUSTRY CHAIN ANALYSIS
4.1 Vaccine (Include COVID-19) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCINE (INCLUDE COVID-19) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VACCINE (INCLUDE COVID-19) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine (Include COVID-19) Sales Market Share by Type (2019-2024)
6.3 Global Vaccine (Include COVID-19) Market Size Market Share by Type (2019-2024)
6.4 Global Vaccine (Include COVID-19) Price by Type (2019-2024)
7 VACCINE (INCLUDE COVID-19) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine (Include COVID-19) Market Sales by Application (2019-2024)
7.3 Global Vaccine (Include COVID-19) Market Size (M USD) by Application (2019-2024)
7.4 Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2019-2024)
8 VACCINE (INCLUDE COVID-19) MARKET CONSUMPTION BY REGION
8.1 Global Vaccine (Include COVID-19) Sales by Region
8.1.1 Global Vaccine (Include COVID-19) Sales by Region
8.1.2 Global Vaccine (Include COVID-19) Sales Market Share by Region
8.2 North America
8.2.1 North America Vaccine (Include COVID-19) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vaccine (Include COVID-19) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vaccine (Include COVID-19) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vaccine (Include COVID-19) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vaccine (Include COVID-19) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 VACCINE (INCLUDE COVID-19) MARKET PRODUCTION BY REGION
9.1 Global Production of Vaccine (Include COVID-19) by Region (2019-2024)
9.2 Global Vaccine (Include COVID-19) Revenue Market Share by Region (2019-2024)
9.3 Global Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Vaccine (Include COVID-19) Production
9.4.1 North America Vaccine (Include COVID-19) Production Growth Rate (2019-2024)
9.4.2 North America Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Vaccine (Include COVID-19) Production
9.5.1 Europe Vaccine (Include COVID-19) Production Growth Rate (2019-2024)
9.5.2 Europe Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Vaccine (Include COVID-19) Production (2019-2024)
9.6.1 Japan Vaccine (Include COVID-19) Production Growth Rate (2019-2024)
9.6.2 Japan Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Vaccine (Include COVID-19) Production (2019-2024)
9.7.1 China Vaccine (Include COVID-19) Production Growth Rate (2019-2024)
9.7.2 China Vaccine (Include COVID-19) Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Vaccine (Include COVID-19) Basic Information
10.1.2 Sanofi Vaccine (Include COVID-19) Product Overview
10.1.3 Sanofi Vaccine (Include COVID-19) Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi Vaccine (Include COVID-19) SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Vaccine (Include COVID-19) Basic Information
10.2.2 CSL Vaccine (Include COVID-19) Product Overview
10.2.3 CSL Vaccine (Include COVID-19) Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL Vaccine (Include COVID-19) SWOT Analysis
10.2.6 CSL Recent Developments
10.3 GSK
10.3.1 GSK Vaccine (Include COVID-19) Basic Information
10.3.2 GSK Vaccine (Include COVID-19) Product Overview
10.3.3 GSK Vaccine (Include COVID-19) Product Market Performance
10.3.4 GSK Vaccine (Include COVID-19) SWOT Analysis
10.3.5 GSK Business Overview
10.3.6 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Vaccine (Include COVID-19) Basic Information
10.4.2 Viatris Vaccine (Include COVID-19) Product Overview
10.4.3 Viatris Vaccine (Include COVID-19) Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Vaccine (Include COVID-19) Basic Information
10.5.2 AstraZeneca Vaccine (Include COVID-19) Product Overview
10.5.3 AstraZeneca Vaccine (Include COVID-19) Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Vaccine (Include COVID-19) Basic Information
10.6.2 Hualan Bio Vaccine (Include COVID-19) Product Overview
10.6.3 Hualan Bio Vaccine (Include COVID-19) Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Vaccine (Include COVID-19) Basic Information
10.7.2 Changchun Institute of Biological Vaccine (Include COVID-19) Product Overview
10.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Product Market Performance
10.7.4 Changchun Institute of Biological Business Overview
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Vaccine (Include COVID-19) Basic Information
10.8.2 Sinovac Vaccine (Include COVID-19) Product Overview
10.8.3 Sinovac Vaccine (Include COVID-19) Product Market Performance
10.8.4 Sinovac Business Overview
10.8.5 Sinovac Recent Developments
10.9 KM Biologics
10.9.1 KM Biologics Vaccine (Include COVID-19) Basic Information
10.9.2 KM Biologics Vaccine (Include COVID-19) Product Overview
10.9.3 KM Biologics Vaccine (Include COVID-19) Product Market Performance
10.9.4 KM Biologics Business Overview
10.9.5 KM Biologics Recent Developments
10.10 Pfizer
10.10.1 Pfizer Vaccine (Include COVID-19) Basic Information
10.10.2 Pfizer Vaccine (Include COVID-19) Product Overview
10.10.3 Pfizer Vaccine (Include COVID-19) Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
10.11 Merck
10.11.1 Merck Vaccine (Include COVID-19) Basic Information
10.11.2 Merck Vaccine (Include COVID-19) Product Overview
10.11.3 Merck Vaccine (Include COVID-19) Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 Sinovac
10.12.1 Sinovac Vaccine (Include COVID-19) Basic Information
10.12.2 Sinovac Vaccine (Include COVID-19) Product Overview
10.12.3 Sinovac Vaccine (Include COVID-19) Product Market Performance
10.12.4 Sinovac Business Overview
10.12.5 Sinovac Recent Developments
10.13 Zhejiang Pukang
10.13.1 Zhejiang Pukang Vaccine (Include COVID-19) Basic Information
10.13.2 Zhejiang Pukang Vaccine (Include COVID-19) Product Overview
10.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Product Market Performance
10.13.4 Zhejiang Pukang Business Overview
10.13.5 Zhejiang Pukang Recent Developments
10.14 Walvax Biotechnology
10.14.1 Walvax Biotechnology Vaccine (Include COVID-19) Basic Information
10.14.2 Walvax Biotechnology Vaccine (Include COVID-19) Product Overview
10.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Product Market Performance
10.14.4 Walvax Biotechnology Business Overview
10.14.5 Walvax Biotechnology Recent Developments
10.15 Bharat Biotech
10.15.1 Bharat Biotech Vaccine (Include COVID-19) Basic Information
10.15.2 Bharat Biotech Vaccine (Include COVID-19) Product Overview
10.15.3 Bharat Biotech Vaccine (Include COVID-19) Product Market Performance
10.15.4 Bharat Biotech Business Overview
10.15.5 Bharat Biotech Recent Developments
10.16 Serum Institute
10.16.1 Serum Institute Vaccine (Include COVID-19) Basic Information
10.16.2 Serum Institute Vaccine (Include COVID-19) Product Overview
10.16.3 Serum Institute Vaccine (Include COVID-19) Product Market Performance
10.16.4 Serum Institute Business Overview
10.16.5 Serum Institute Recent Developments
10.17 Panacea Biotec Ltd
10.17.1 Panacea Biotec Ltd Vaccine (Include COVID-19) Basic Information
10.17.2 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Overview
10.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Market Performance
10.17.4 Panacea Biotec Ltd Business Overview
10.17.5 Panacea Biotec Ltd Recent Developments
10.18 Bio-Med
10.18.1 Bio-Med Vaccine (Include COVID-19) Basic Information
10.18.2 Bio-Med Vaccine (Include COVID-19) Product Overview
10.18.3 Bio-Med Vaccine (Include COVID-19) Product Market Performance
10.18.4 Bio-Med Business Overview
10.18.5 Bio-Med Recent Developments
10.19 Halfkin Bio-Pharmaceuticals
10.19.1 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Basic Information
10.19.2 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Overview
10.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Market Performance
10.19.4 Halfkin Bio-Pharmaceuticals Business Overview
10.19.5 Halfkin Bio-Pharmaceuticals Recent Developments
10.20 LG Life Sciences
10.20.1 LG Life Sciences Vaccine (Include COVID-19) Basic Information
10.20.2 LG Life Sciences Vaccine (Include COVID-19) Product Overview
10.20.3 LG Life Sciences Vaccine (Include COVID-19) Product Market Performance
10.20.4 LG Life Sciences Business Overview
10.20.5 LG Life Sciences Recent Developments
11 VACCINE (INCLUDE COVID-19) MARKET FORECAST BY REGION
11.1 Global Vaccine (Include COVID-19) Market Size Forecast
11.2 Global Vaccine (Include COVID-19) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaccine (Include COVID-19) Market Size Forecast by Country
11.2.3 Asia Pacific Vaccine (Include COVID-19) Market Size Forecast by Region
11.2.4 South America Vaccine (Include COVID-19) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Vaccine (Include COVID-19) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Vaccine (Include COVID-19) Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Vaccine (Include COVID-19) by Type (2025-2032)
12.1.2 Global Vaccine (Include COVID-19) Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Vaccine (Include COVID-19) by Type (2025-2032)
12.2 Global Vaccine (Include COVID-19) Market Forecast by Application (2025-2032)
12.2.1 Global Vaccine (Include COVID-19) Sales (K MT) Forecast by Application
12.2.2 Global Vaccine (Include COVID-19) Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vaccine (Include COVID-19) Market Size Comparison by Region (M USD)
Table 5. Global Vaccine (Include COVID-19) Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Vaccine (Include COVID-19) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Vaccine (Include COVID-19) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Vaccine (Include COVID-19) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine (Include COVID-19) as of 2022)
Table 10. Global Market Vaccine (Include COVID-19) Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Vaccine (Include COVID-19) Sales Sites and Area Served
Table 12. Manufacturers Vaccine (Include COVID-19) Product Type
Table 13. Global Vaccine (Include COVID-19) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Vaccine (Include COVID-19)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaccine (Include COVID-19) Market Challenges
Table 22. Global Vaccine (Include COVID-19) Sales by Type (K MT)
Table 23. Global Vaccine (Include COVID-19) Market Size by Type (M USD)
Table 24. Global Vaccine (Include COVID-19) Sales (K MT) by Type (2019-2024)
Table 25. Global Vaccine (Include COVID-19) Sales Market Share by Type (2019-2024)
Table 26. Global Vaccine (Include COVID-19) Market Size (M USD) by Type (2019-2024)
Table 27. Global Vaccine (Include COVID-19) Market Size Share by Type (2019-2024)
Table 28. Global Vaccine (Include COVID-19) Price (USD/MT) by Type (2019-2024)
Table 29. Global Vaccine (Include COVID-19) Sales (K MT) by Application
Table 30. Global Vaccine (Include COVID-19) Market Size by Application
Table 31. Global Vaccine (Include COVID-19) Sales by Application (2019-2024) & (K MT)
Table 32. Global Vaccine (Include COVID-19) Sales Market Share by Application (2019-2024)
Table 33. Global Vaccine (Include COVID-19) Sales by Application (2019-2024) & (M USD)
Table 34. Global Vaccine (Include COVID-19) Market Share by Application (2019-2024)
Table 35. Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2019-2024)
Table 36. Global Vaccine (Include COVID-19) Sales by Region (2019-2024) & (K MT)
Table 37. Global Vaccine (Include COVID-19) Sales Market Share by Region (2019-2024)
Table 38. North America Vaccine (Include COVID-19) Sales by Country (2019-2024) & (K MT)
Table 39. Europe Vaccine (Include COVID-19) Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Vaccine (Include COVID-19) Sales by Region (2019-2024) & (K MT)
Table 41. South America Vaccine (Include COVID-19) Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Vaccine (Include COVID-19) Sales by Region (2019-2024) & (K MT)
Table 43. Global Vaccine (Include COVID-19) Production (K MT) by Region (2019-2024)
Table 44. Global Vaccine (Include COVID-19) Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Vaccine (Include COVID-19) Revenue Market Share by Region (2019-2024)
Table 46. Global Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Sanofi Vaccine (Include COVID-19) Basic Information
Table 52. Sanofi Vaccine (Include COVID-19) Product Overview
Table 53. Sanofi Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Sanofi Business Overview
Table 55. Sanofi Vaccine (Include COVID-19) SWOT Analysis
Table 56. Sanofi Recent Developments
Table 57. CSL Vaccine (Include COVID-19) Basic Information
Table 58. CSL Vaccine (Include COVID-19) Product Overview
Table 59. CSL Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. CSL Business Overview
Table 61. CSL Vaccine (Include COVID-19) SWOT Analysis
Table 62. CSL Recent Developments
Table 63. GSK Vaccine (Include COVID-19) Basic Information
Table 64. GSK Vaccine (Include COVID-19) Product Overview
Table 65. GSK Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. GSK Vaccine (Include COVID-19) SWOT Analysis
Table 67. GSK Business Overview
Table 68. GSK Recent Developments
Table 69. Viatris Vaccine (Include COVID-19) Basic Information
Table 70. Viatris Vaccine (Include COVID-19) Product Overview
Table 71. Viatris Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Viatris Business Overview
Table 73. Viatris Recent Developments
Table 74. AstraZeneca Vaccine (Include COVID-19) Basic Information
Table 75. AstraZeneca Vaccine (Include COVID-19) Product Overview
Table 76. AstraZeneca Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Recent Developments
Table 79. Hualan Bio Vaccine (Include COVID-19) Basic Information
Table 80. Hualan Bio Vaccine (Include COVID-19) Product Overview
Table 81. Hualan Bio Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Hualan Bio Business Overview
Table 83. Hualan Bio Recent Developments
Table 84. Changchun Institute of Biological Vaccine (Include COVID-19) Basic Information
Table 85. Changchun Institute of Biological Vaccine (Include COVID-19) Product Overview
Table 86. Changchun Institute of Biological Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Changchun Institute of Biological Business Overview
Table 88. Changchun Institute of Biological Recent Developments
Table 89. Sinovac Vaccine (Include COVID-19) Basic Information
Table 90. Sinovac Vaccine (Include COVID-19) Product Overview
Table 91. Sinovac Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Sinovac Business Overview
Table 93. Sinovac Recent Developments
Table 94. KM Biologics Vaccine (Include COVID-19) Basic Information
Table 95. KM Biologics Vaccine (Include COVID-19) Product Overview
Table 96. KM Biologics Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. KM Biologics Business Overview
Table 98. KM Biologics Recent Developments
Table 99. Pfizer Vaccine (Include COVID-19) Basic Information
Table 100. Pfizer Vaccine (Include COVID-19) Product Overview
Table 101. Pfizer Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. Merck Vaccine (Include COVID-19) Basic Information
Table 105. Merck Vaccine (Include COVID-19) Product Overview
Table 106. Merck Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Merck Business Overview
Table 108. Merck Recent Developments
Table 109. Sinovac Vaccine (Include COVID-19) Basic Information
Table 110. Sinovac Vaccine (Include COVID-19) Product Overview
Table 111. Sinovac Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Sinovac Business Overview
Table 113. Sinovac Recent Developments
Table 114. Zhejiang Pukang Vaccine (Include COVID-19) Basic Information
Table 115. Zhejiang Pukang Vaccine (Include COVID-19) Product Overview
Table 116. Zhejiang Pukang Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Zhejiang Pukang Business Overview
Table 118. Zhejiang Pukang Recent Developments
Table 119. Walvax Biotechnology Vaccine (Include COVID-19) Basic Information
Table 120. Walvax Biotechnology Vaccine (Include COVID-19) Product Overview
Table 121. Walvax Biotechnology Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Walvax Biotechnology Business Overview
Table 123. Walvax Biotechnology Recent Developments
Table 124. Bharat Biotech Vaccine (Include COVID-19) Basic Information
Table 125. Bharat Biotech Vaccine (Include COVID-19) Product Overview
Table 126. Bharat Biotech Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Bharat Biotech Business Overview
Table 128. Bharat Biotech Recent Developments
Table 129. Serum Institute Vaccine (Include COVID-19) Basic Information
Table 130. Serum Institute Vaccine (Include COVID-19) Product Overview
Table 131. Serum Institute Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Serum Institute Business Overview
Table 133. Serum Institute Recent Developments
Table 134. Panacea Biotec Ltd Vaccine (Include COVID-19) Basic Information
Table 135. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Overview
Table 136. Panacea Biotec Ltd Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Panacea Biotec Ltd Business Overview
Table 138. Panacea Biotec Ltd Recent Developments
Table 139. Bio-Med Vaccine (Include COVID-19) Basic Information
Table 140. Bio-Med Vaccine (Include COVID-19) Product Overview
Table 141. Bio-Med Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Bio-Med Business Overview
Table 143. Bio-Med Recent Developments
Table 144. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Basic Information
Table 145. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Overview
Table 146. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Halfkin Bio-Pharmaceuticals Business Overview
Table 148. Halfkin Bio-Pharmaceuticals Recent Developments
Table 149. LG Life Sciences Vaccine (Include COVID-19) Basic Information
Table 150. LG Life Sciences Vaccine (Include COVID-19) Product Overview
Table 151. LG Life Sciences Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. LG Life Sciences Business Overview
Table 153. LG Life Sciences Recent Developments
Table 154. Global Vaccine (Include COVID-19) Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Vaccine (Include COVID-19) Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Vaccine (Include COVID-19) Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Vaccine (Include COVID-19) Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Vaccine (Include COVID-19) Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Vaccine (Include COVID-19) Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Vaccine (Include COVID-19) Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Vaccine (Include COVID-19) Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Vaccine (Include COVID-19) Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Vaccine (Include COVID-19) Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Vaccine (Include COVID-19) Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Vaccine (Include COVID-19) Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Vaccine (Include COVID-19) Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Vaccine (Include COVID-19) Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Vaccine (Include COVID-19) Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Vaccine (Include COVID-19) Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Vaccine (Include COVID-19) Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vaccine (Include COVID-19) Market Size Comparison by Region (M USD)
Table 5. Global Vaccine (Include COVID-19) Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Vaccine (Include COVID-19) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Vaccine (Include COVID-19) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Vaccine (Include COVID-19) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine (Include COVID-19) as of 2022)
Table 10. Global Market Vaccine (Include COVID-19) Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Vaccine (Include COVID-19) Sales Sites and Area Served
Table 12. Manufacturers Vaccine (Include COVID-19) Product Type
Table 13. Global Vaccine (Include COVID-19) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Vaccine (Include COVID-19)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaccine (Include COVID-19) Market Challenges
Table 22. Global Vaccine (Include COVID-19) Sales by Type (K MT)
Table 23. Global Vaccine (Include COVID-19) Market Size by Type (M USD)
Table 24. Global Vaccine (Include COVID-19) Sales (K MT) by Type (2019-2024)
Table 25. Global Vaccine (Include COVID-19) Sales Market Share by Type (2019-2024)
Table 26. Global Vaccine (Include COVID-19) Market Size (M USD) by Type (2019-2024)
Table 27. Global Vaccine (Include COVID-19) Market Size Share by Type (2019-2024)
Table 28. Global Vaccine (Include COVID-19) Price (USD/MT) by Type (2019-2024)
Table 29. Global Vaccine (Include COVID-19) Sales (K MT) by Application
Table 30. Global Vaccine (Include COVID-19) Market Size by Application
Table 31. Global Vaccine (Include COVID-19) Sales by Application (2019-2024) & (K MT)
Table 32. Global Vaccine (Include COVID-19) Sales Market Share by Application (2019-2024)
Table 33. Global Vaccine (Include COVID-19) Sales by Application (2019-2024) & (M USD)
Table 34. Global Vaccine (Include COVID-19) Market Share by Application (2019-2024)
Table 35. Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2019-2024)
Table 36. Global Vaccine (Include COVID-19) Sales by Region (2019-2024) & (K MT)
Table 37. Global Vaccine (Include COVID-19) Sales Market Share by Region (2019-2024)
Table 38. North America Vaccine (Include COVID-19) Sales by Country (2019-2024) & (K MT)
Table 39. Europe Vaccine (Include COVID-19) Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Vaccine (Include COVID-19) Sales by Region (2019-2024) & (K MT)
Table 41. South America Vaccine (Include COVID-19) Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Vaccine (Include COVID-19) Sales by Region (2019-2024) & (K MT)
Table 43. Global Vaccine (Include COVID-19) Production (K MT) by Region (2019-2024)
Table 44. Global Vaccine (Include COVID-19) Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Vaccine (Include COVID-19) Revenue Market Share by Region (2019-2024)
Table 46. Global Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Vaccine (Include COVID-19) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Sanofi Vaccine (Include COVID-19) Basic Information
Table 52. Sanofi Vaccine (Include COVID-19) Product Overview
Table 53. Sanofi Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Sanofi Business Overview
Table 55. Sanofi Vaccine (Include COVID-19) SWOT Analysis
Table 56. Sanofi Recent Developments
Table 57. CSL Vaccine (Include COVID-19) Basic Information
Table 58. CSL Vaccine (Include COVID-19) Product Overview
Table 59. CSL Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. CSL Business Overview
Table 61. CSL Vaccine (Include COVID-19) SWOT Analysis
Table 62. CSL Recent Developments
Table 63. GSK Vaccine (Include COVID-19) Basic Information
Table 64. GSK Vaccine (Include COVID-19) Product Overview
Table 65. GSK Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. GSK Vaccine (Include COVID-19) SWOT Analysis
Table 67. GSK Business Overview
Table 68. GSK Recent Developments
Table 69. Viatris Vaccine (Include COVID-19) Basic Information
Table 70. Viatris Vaccine (Include COVID-19) Product Overview
Table 71. Viatris Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Viatris Business Overview
Table 73. Viatris Recent Developments
Table 74. AstraZeneca Vaccine (Include COVID-19) Basic Information
Table 75. AstraZeneca Vaccine (Include COVID-19) Product Overview
Table 76. AstraZeneca Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Recent Developments
Table 79. Hualan Bio Vaccine (Include COVID-19) Basic Information
Table 80. Hualan Bio Vaccine (Include COVID-19) Product Overview
Table 81. Hualan Bio Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Hualan Bio Business Overview
Table 83. Hualan Bio Recent Developments
Table 84. Changchun Institute of Biological Vaccine (Include COVID-19) Basic Information
Table 85. Changchun Institute of Biological Vaccine (Include COVID-19) Product Overview
Table 86. Changchun Institute of Biological Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Changchun Institute of Biological Business Overview
Table 88. Changchun Institute of Biological Recent Developments
Table 89. Sinovac Vaccine (Include COVID-19) Basic Information
Table 90. Sinovac Vaccine (Include COVID-19) Product Overview
Table 91. Sinovac Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Sinovac Business Overview
Table 93. Sinovac Recent Developments
Table 94. KM Biologics Vaccine (Include COVID-19) Basic Information
Table 95. KM Biologics Vaccine (Include COVID-19) Product Overview
Table 96. KM Biologics Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. KM Biologics Business Overview
Table 98. KM Biologics Recent Developments
Table 99. Pfizer Vaccine (Include COVID-19) Basic Information
Table 100. Pfizer Vaccine (Include COVID-19) Product Overview
Table 101. Pfizer Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. Merck Vaccine (Include COVID-19) Basic Information
Table 105. Merck Vaccine (Include COVID-19) Product Overview
Table 106. Merck Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Merck Business Overview
Table 108. Merck Recent Developments
Table 109. Sinovac Vaccine (Include COVID-19) Basic Information
Table 110. Sinovac Vaccine (Include COVID-19) Product Overview
Table 111. Sinovac Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Sinovac Business Overview
Table 113. Sinovac Recent Developments
Table 114. Zhejiang Pukang Vaccine (Include COVID-19) Basic Information
Table 115. Zhejiang Pukang Vaccine (Include COVID-19) Product Overview
Table 116. Zhejiang Pukang Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Zhejiang Pukang Business Overview
Table 118. Zhejiang Pukang Recent Developments
Table 119. Walvax Biotechnology Vaccine (Include COVID-19) Basic Information
Table 120. Walvax Biotechnology Vaccine (Include COVID-19) Product Overview
Table 121. Walvax Biotechnology Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Walvax Biotechnology Business Overview
Table 123. Walvax Biotechnology Recent Developments
Table 124. Bharat Biotech Vaccine (Include COVID-19) Basic Information
Table 125. Bharat Biotech Vaccine (Include COVID-19) Product Overview
Table 126. Bharat Biotech Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Bharat Biotech Business Overview
Table 128. Bharat Biotech Recent Developments
Table 129. Serum Institute Vaccine (Include COVID-19) Basic Information
Table 130. Serum Institute Vaccine (Include COVID-19) Product Overview
Table 131. Serum Institute Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Serum Institute Business Overview
Table 133. Serum Institute Recent Developments
Table 134. Panacea Biotec Ltd Vaccine (Include COVID-19) Basic Information
Table 135. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Overview
Table 136. Panacea Biotec Ltd Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Panacea Biotec Ltd Business Overview
Table 138. Panacea Biotec Ltd Recent Developments
Table 139. Bio-Med Vaccine (Include COVID-19) Basic Information
Table 140. Bio-Med Vaccine (Include COVID-19) Product Overview
Table 141. Bio-Med Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Bio-Med Business Overview
Table 143. Bio-Med Recent Developments
Table 144. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Basic Information
Table 145. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Overview
Table 146. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Halfkin Bio-Pharmaceuticals Business Overview
Table 148. Halfkin Bio-Pharmaceuticals Recent Developments
Table 149. LG Life Sciences Vaccine (Include COVID-19) Basic Information
Table 150. LG Life Sciences Vaccine (Include COVID-19) Product Overview
Table 151. LG Life Sciences Vaccine (Include COVID-19) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. LG Life Sciences Business Overview
Table 153. LG Life Sciences Recent Developments
Table 154. Global Vaccine (Include COVID-19) Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Vaccine (Include COVID-19) Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Vaccine (Include COVID-19) Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Vaccine (Include COVID-19) Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Vaccine (Include COVID-19) Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Vaccine (Include COVID-19) Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Vaccine (Include COVID-19) Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Vaccine (Include COVID-19) Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Vaccine (Include COVID-19) Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Vaccine (Include COVID-19) Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Vaccine (Include COVID-19) Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Vaccine (Include COVID-19) Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Vaccine (Include COVID-19) Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Vaccine (Include COVID-19) Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Vaccine (Include COVID-19) Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Vaccine (Include COVID-19) Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Vaccine (Include COVID-19) Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Vaccine (Include COVID-19)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccine (Include COVID-19) Market Size (M USD), 2019-2032
Figure 5. Global Vaccine (Include COVID-19) Market Size (M USD) (2019-2032)
Figure 6. Global Vaccine (Include COVID-19) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccine (Include COVID-19) Market Size by Country (M USD)
Figure 11. Vaccine (Include COVID-19) Sales Share by Manufacturers in 2023
Figure 12. Global Vaccine (Include COVID-19) Revenue Share by Manufacturers in 2023
Figure 13. Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Vaccine (Include COVID-19) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Vaccine (Include COVID-19) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Vaccine (Include COVID-19) Market Share by Type
Figure 18. Sales Market Share of Vaccine (Include COVID-19) by Type (2019-2024)
Figure 19. Sales Market Share of Vaccine (Include COVID-19) by Type in 2023
Figure 20. Market Size Share of Vaccine (Include COVID-19) by Type (2019-2024)
Figure 21. Market Size Market Share of Vaccine (Include COVID-19) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Vaccine (Include COVID-19) Market Share by Application
Figure 24. Global Vaccine (Include COVID-19) Sales Market Share by Application (2019-2024)
Figure 25. Global Vaccine (Include COVID-19) Sales Market Share by Application in 2023
Figure 26. Global Vaccine (Include COVID-19) Market Share by Application (2019-2024)
Figure 27. Global Vaccine (Include COVID-19) Market Share by Application in 2023
Figure 28. Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Vaccine (Include COVID-19) Sales Market Share by Region (2019-2024)
Figure 30. North America Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Vaccine (Include COVID-19) Sales Market Share by Country in 2023
Figure 32. U.S. Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Vaccine (Include COVID-19) Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Vaccine (Include COVID-19) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Vaccine (Include COVID-19) Sales Market Share by Country in 2023
Figure 37. Germany Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Vaccine (Include COVID-19) Sales Market Share by Region in 2023
Figure 44. China Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 50. South America Vaccine (Include COVID-19) Sales Market Share by Country in 2023
Figure 51. Brazil Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Vaccine (Include COVID-19) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Vaccine (Include COVID-19) Production Market Share by Region (2019-2024)
Figure 62. North America Vaccine (Include COVID-19) Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Vaccine (Include COVID-19) Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Vaccine (Include COVID-19) Production (K MT) Growth Rate (2019-2024)
Figure 65. China Vaccine (Include COVID-19) Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Vaccine (Include COVID-19) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Vaccine (Include COVID-19) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Vaccine (Include COVID-19) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Vaccine (Include COVID-19) Market Share Forecast by Type (2025-2032)
Figure 70. Global Vaccine (Include COVID-19) Sales Forecast by Application (2025-2032)
Figure 71. Global Vaccine (Include COVID-19) Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Vaccine (Include COVID-19)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaccine (Include COVID-19) Market Size (M USD), 2019-2032
Figure 5. Global Vaccine (Include COVID-19) Market Size (M USD) (2019-2032)
Figure 6. Global Vaccine (Include COVID-19) Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaccine (Include COVID-19) Market Size by Country (M USD)
Figure 11. Vaccine (Include COVID-19) Sales Share by Manufacturers in 2023
Figure 12. Global Vaccine (Include COVID-19) Revenue Share by Manufacturers in 2023
Figure 13. Vaccine (Include COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Vaccine (Include COVID-19) Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Vaccine (Include COVID-19) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Vaccine (Include COVID-19) Market Share by Type
Figure 18. Sales Market Share of Vaccine (Include COVID-19) by Type (2019-2024)
Figure 19. Sales Market Share of Vaccine (Include COVID-19) by Type in 2023
Figure 20. Market Size Share of Vaccine (Include COVID-19) by Type (2019-2024)
Figure 21. Market Size Market Share of Vaccine (Include COVID-19) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Vaccine (Include COVID-19) Market Share by Application
Figure 24. Global Vaccine (Include COVID-19) Sales Market Share by Application (2019-2024)
Figure 25. Global Vaccine (Include COVID-19) Sales Market Share by Application in 2023
Figure 26. Global Vaccine (Include COVID-19) Market Share by Application (2019-2024)
Figure 27. Global Vaccine (Include COVID-19) Market Share by Application in 2023
Figure 28. Global Vaccine (Include COVID-19) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Vaccine (Include COVID-19) Sales Market Share by Region (2019-2024)
Figure 30. North America Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Vaccine (Include COVID-19) Sales Market Share by Country in 2023
Figure 32. U.S. Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Vaccine (Include COVID-19) Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Vaccine (Include COVID-19) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Vaccine (Include COVID-19) Sales Market Share by Country in 2023
Figure 37. Germany Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Vaccine (Include COVID-19) Sales Market Share by Region in 2023
Figure 44. China Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 50. South America Vaccine (Include COVID-19) Sales Market Share by Country in 2023
Figure 51. Brazil Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Vaccine (Include COVID-19) Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Vaccine (Include COVID-19) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Vaccine (Include COVID-19) Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Vaccine (Include COVID-19) Production Market Share by Region (2019-2024)
Figure 62. North America Vaccine (Include COVID-19) Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Vaccine (Include COVID-19) Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Vaccine (Include COVID-19) Production (K MT) Growth Rate (2019-2024)
Figure 65. China Vaccine (Include COVID-19) Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Vaccine (Include COVID-19) Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Vaccine (Include COVID-19) Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Vaccine (Include COVID-19) Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Vaccine (Include COVID-19) Market Share Forecast by Type (2025-2032)
Figure 70. Global Vaccine (Include COVID-19) Sales Forecast by Application (2025-2032)
Figure 71. Global Vaccine (Include COVID-19) Market Share Forecast by Application (2025-2032)
